Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Thyrocare Technologies Annual General Meeting

Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.

Source

NSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Thyrocare Technologies Ltd: key numbers

Share price
₹515.50
Market cap
₹8,205 Cr
Revenue (annual)
₹829.0 Cr
Net profit (annual)
₹163.0 Cr
P/E (TTM)
56.9×Sector 52.3×
Promoter holding
51.02%-9.90% QoQ
FII holding
9.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Thyrocare Technologies Ltd

All →

Other annual general meeting announcements

All →